A small provider of infection prevention products continues to attract plenty of investor attention as new licence agreements could help drive significant growth in the world’s largest market. However, as our update here suggests, it's very hard to gauge the market potential
Byotrol: new licence agreements see shares leap again
Shares in Byotrol (LON:BYOT), the infection prevention and control technology company, leaped on news of two new license agreements and confirmation of continued strong trading.
The group has agreed a technology license over Byotrol24, its EPA registered long-lasting germ kill sanitiser spray, with a consortium of investors and experienced market professionals under the umbrella of Integrated Resources International LLC. The license is for 10 years and gives exclusive…
Access the all latest company comments on Investor's Champion.
Not yet registered? It's free to register. Register now.
Register on Investor's Champion
Access the all latest company comments on Investor's Champion.
Premium Content
Premium content provides more in-depth information on fascinating investment stories and research to help make your money go further.
Access Premium Content through individual credits (we only want you to read what you are interested in) or through an annual subscription, which works out as only 25p per day – a small price to guide you through the investing maze!
Subscription
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
In depth coverage of many of the world’s great companies
Breaking news on potential upcoming disasters
Unique insights from our top research team
Credits
Get access to our premium content for as little as £3.20 per article.